Cardiovascular disease (CVD) affects more than 71 million Americans accounting annually for nearly $400 billion in US health care costs. [1] In adult tissues such as the heart, the capacity for self-regeneration is limited. Recently, stem cell therapy has emerged as a promising methodology for myocardial repair.

This content is only available via PDF.
You do not currently have access to this content.